Savara (SVRA) Operating Expenses (2010 - 2026)

Savara (SVRA) reported Operating Expenses of $39.0 million for Q1 2026, up 37.12% year-over-year from $28.4 million in Q1 2025, and up 16.67% on a QoQ basis from $33.4 million in Q4 2025.

Savara (SVRA) has 17 years of Operating Expenses data on file, last reported at $39.0 million in Q1 2026.

  • Quarterly Operating Expenses rose 37.12% year-over-year to $39.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $134.1 million (up 22.86% YoY) and the FY2025 annual result came in at $123.5 million, up 19.72% from the prior year.
  • Operating Expenses improved to $39.0 million in Q1 2026 per SVRA's latest filing, from $33.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $39.0 million in Q1 2026 and bottomed at $8.0 million in Q1 2022.
  • The 5-year median for Operating Expenses is $22.5 million (2024), against an average of $21.4 million.
  • The widest annual swing landed in 2022, when Operating Expenses dropped 22.74%; it then soared 89.76% in 2024.
  • Tracing SVRA's Operating Expenses over 5 years: stood at $10.9 million in 2022, then jumped by 62.11% to $17.6 million in 2023, then jumped by 76.82% to $31.2 million in 2024, then rose by 7.2% to $33.4 million in 2025, then rose by 16.67% to $39.0 million in 2026.
  • Per Business Quant, the three latest SVRA Operating Expenses figures stand at $39.0 million (Q1 2026), $33.4 million (Q4 2025), and $30.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.97 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.33 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -138.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 15.76 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.85 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 898.54 Mn
10 Savara 1.30 Bn 1.30 Bn - 38.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.99 Mn
Dec 31, 2025 33.42 Mn
Sep 30, 2025 30.26 Mn
Jun 30, 2025 31.44 Mn
Mar 31, 2025 28.44 Mn
Dec 31, 2024 31.17 Mn
Sep 30, 2024 26.36 Mn
Jun 30, 2024 23.19 Mn
Mar 31, 2024 22.48 Mn
Dec 31, 2023 17.63 Mn
Sep 30, 2023 18.04 Mn
Jun 30, 2023 12.22 Mn
Mar 31, 2023 12.11 Mn
Dec 31, 2022 10.88 Mn
Sep 30, 2022 10.54 Mn
Jun 30, 2022 9.38 Mn
Mar 31, 2022 8.05 Mn
Dec 31, 2021 10.64 Mn
Sep 30, 2021 9.97 Mn
Jun 30, 2021 10.45 Mn
Mar 31, 2021 10.41 Mn
Dec 31, 2020 13.01 Mn
Sep 30, 2020 11.04 Mn
Jun 30, 2020 9.26 Mn
Mar 31, 2020 16.24 Mn
Dec 31, 2019 31.51 Mn
Sep 30, 2019 12.44 Mn
Jun 30, 2019 22.15 Mn
Mar 31, 2019 12.92 Mn
Dec 31, 2018 13.25 Mn
Sep 30, 2018 12.78 Mn
Jun 30, 2018 11.91 Mn
Mar 31, 2018 32.11 Mn
Dec 31, 2017 9.20 Mn
Sep 30, 2017 6.54 Mn
Jun 30, 2017 9.34 Mn
Mar 31, 2017 4.77 Mn
Dec 31, 2016 4.44 Mn
Sep 30, 2016 3.23 Mn
Jun 30, 2016 1.98 Mn
Mar 31, 2016 10.74 Mn
Dec 31, 2015 -23.68 Mn
Sep 30, 2015 9.83 Mn
Jun 30, 2015 10.18 Mn
Mar 31, 2015 9.65 Mn
Dec 31, 2014 1.80 Mn
Sep 30, 2014 7.88 Mn
Jun 30, 2014 7.20 Mn
Mar 31, 2014 6.84 Mn
Dec 31, 2013 5.72 Mn
Sep 30, 2013 5.27 Mn
Jun 30, 2013 4.95 Mn
Mar 31, 2013 5.59 Mn
Dec 31, 2012 4.02 Mn
Sep 30, 2012 3.22 Mn
Jun 30, 2012 4.22 Mn
Mar 31, 2012 4.17 Mn
Dec 31, 2011 2.44 Mn
Sep 30, 2011 3.55 Mn
Jun 30, 2011 4.41 Mn
Mar 31, 2011 2.99 Mn
Dec 31, 2010 2.80 Mn
Sep 30, 2010 1.87 Mn
Jun 30, 2010 1.94 Mn